Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 102102782 | 10210278 | 2 | F | 20140515 | 20140528 | 20140602 | 20150930 | EXP | CL-PFIZER INC-2014147714 | PFIZER | 68.00 | YR | M | Y | 0.00000 | 20150930 | N | CN | CL | CL |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 102102782 | 10210278 | 1 | PS | XALATAN | LATANOPROST | 1 | Ophthalmic | 1 GTT IN EACH EYE, 1X/DAY | D | 20597 | EYE DROPS, SOLUTION | QD | |||||||
| 102102782 | 10210278 | 2 | C | ENALAPRIL | ENALAPRIL | 1 | D | 0 | |||||||||||
| 102102782 | 10210278 | 3 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | D | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 102102782 | 10210278 | 1 | Ocular hypertension |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 102102782 | 10210278 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 102102782 | 10210278 | Ear discomfort | |
| 102102782 | 10210278 | Renal disorder |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 102102782 | 10210278 | 1 | 2007 | 0 |